$DH

Definitive Healthcare stock surges 13% on Advent buyout offer

Definitive Healthcare (NASDAQ:DH) shares rose 13% after Advent International offered to buy the company for $1.02 per share, a 36% premium over its 60-day average. The deal requires approval from a special committee and Jason Krantz's stock rollover. Definitive Healthcare also appointed Clay Ritchey as CEO, replacing Kevin Coop.

Original reporting
Published Sep 2, 2026, 12:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 12:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$DH
Bullish
high confidence
Mentioned
$DH
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$DHBullishHigh
01

Why it matters

The non‑binding offer introduces a clear catalyst for DH's share price, with a sizable premium that may attract other suitors or trigger a bidding war.

02

Market read

First‑report M&A news for DH, prompting a 13% price jump and creating short‑term trading opportunities.

03

What to watch

Potential financing contingencies, regulatory review, and integration risks for Advent International.

Relevance 7/10Novelty 8/10Timing: today

Background

Definitive Healthcare (DH) provides data and analytics to the healthcare industry; Advent International is a private‑equity firm with prior investments in health‑tech.

Company-level read

Ticker impact

$DHBullishHigh confidence
Context

Advent International submitted a non-binding cash offer of $1.02 per share for Definitive Healthcare, driving the stock up 13% on the announcement.

Expected impact

Expect further upside toward the $1.02 offer price, with potential volatility pending special committee approval.

Evidence & confidence

First disclosure of a material M&A proposal for a listed micro‑cap; the premium and immediate share rally indicate strong market reaction.

Market effects

Healthcare data and analytics sector may see consolidation pressure as private equity shows interest.

U.S. small‑cap market could experience a brief lift from the deal news.

Limited to investors tracking M&A activity in the health‑tech space.

Counterpoint

If the special committee deems the offer insufficient or seeks higher bids, the stock could retreat sharply.

Key entities

  • Definitive Healthcare Corp.

    NASDAQ‑listed provider of healthcare data and analytics.

  • Advent International

    Potential acquirer offering $1.02 per share cash.

Related articles

$DHMedAI 8/10

Definitive Healthcare (DH) Q2 2026 Earnings Call

Definitive Healthcare (DH) reported Q2 FY26 revenue of $55.2 million, down 9% year over year, with adjusted EBITDA of $14.6 million and net dollar retention improving for a second straight quarter. Subscription revenue fell 9% to $52.8 million. Full-year guidance: revenue $220-$222 million and adjusted EBITDA $57-$59 million; Q3 revenue $54-$55 million.

$DHHigh

Definitive Healthcare Corp. (DH): Results of Operations and Financial Condition

Definitive Healthcare Corp. (DH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Definitive Healthcare Reports Financial Results for Second Quarter 2026 Second Quarter Revenue Within Guidance Range; Profit Surpasses Expectations Framingham, MA (August 10, 2026) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH),

$PACSMed

PACS Group stock rises on Florida expansion, Eduro closings

PACS Group (NYSE:PACS) shares rose 3.3% premarket after announcing plans to acquire 32 Florida skilled nursing facilities, adding 4,049 beds. The deal, expected to close Q4, expands PACS's southern footprint. Additionally, PACS completed closings on 11 more Eduro Healthcare facilities, bringing total Eduro closings to 31 of 34. The company now operates 355 facilities across 7 states. CEO Jason Murray highlighted Florida's growth potential.

$GPROHighAI 9/10

GoPro has announced a major transformation of

GoPro announced a merger with Starman Optical, a photonics company, to enter defense and AI data center markets. CEO Nicholas Woodman expects this to drive growth in consumer, commercial, and military sectors. The company's stock rose 40% post-announcement, with shareholders receiving $285 million in cash payments. GoPro will continue to support existing products while investing in expansion and diversification.

$ROCMed

Rank One Computing Corp (ROC): Completion of Acquisition or Disposition of Assets

Rank One Computing Corp (ROC) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 ROC Completes Acquisition of ZTC; Strengthening Competitive Position for ROC’s Vision AI Platform Acquisition expands ROC Evidence into an end-to-end investigative intelligence offering by combining proven digital forensics with digital evidence management Adds speci

Definitive Healthcare stock surges 13% on Advent buyout offer — alphai